Insulin therapy is not associated with improved clinical outcomes in critically ill infants with stress hyperglycemia

Area of Science:

• Pediatric Critical Care Medicine
• Endocrinology
• Metabolic Disorders

Background:

• Stress-induced hyperglycemia is common in critically ill infants.
• The role of insulin therapy in managing this condition remains debated.

Purpose of the Study:

• To evaluate the efficacy of insulin therapy versus no insulin in critically ill infants with stress hyperglycemia.
• To assess the impact of insulin on clinical outcomes such as length of stay and mortality.

Main Methods:

• Retrospective study of 302 critically ill infants with stress hyperglycemia.
• Patients were divided into three groups: tight glycemic control, conventional insulin therapy, and control.
• Outcomes analyzed included length of pediatric intensive care unit (PICU) stay, total hospital stay, organ dysfunction, and mortality.

Main Results:

• No statistically significant difference in blood glucose levels was observed between groups at 96 hours post-PICU admission.
• Insulin therapy did not correlate with reduced PICU stay, total stay, mortality, or organ dysfunction.
• Spontaneous normalization of blood glucose occurred in some infants without insulin, without increased risk.

Conclusions:

• Insulin therapy offers no discernible benefit for critically ill pediatric patients experiencing stress hyperglycemia.
• Management strategies should consider the potential for spontaneous glucose normalization and avoid unnecessary insulin administration.
• Further research may explore individualized approaches to hyperglycemia in this vulnerable population.